Healthpeak Properties, Inc. $DOC Shares Sold by Nissay Asset Management Corp Japan

Key Points

• Nissay Asset Management cut its Healthpeak Properties stake by 46% in the second quarter, selling 91,913 shares and retaining 108,049 shares valued at approximately $2.3 million. Institutional investors collectively own 93.57% of the company.
• Analyst sentiment remains cautious, with a consensus “Hold” rating and a $21.72 price target; four analysts rate the stock a Buy while fourteen rate it a Hold.
• Healthpeak exceeded quarterly earnings and revenue expectations, reporting $0.08 EPS and $771.6 million in revenue, while declaring a monthly dividend of $0.1017 per share representing an indicated 5.9% yield.

Nissay Asset Management Corp Japan trimmed its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 46.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 108,049 shares of the real estate investment trust's stock after selling 91,913 shares during the period. Nissay Asset Management Corp Japan's holdings in Healthpeak Properties were worth $2,312,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Bank of America Corp DE purchased a new position in Healthpeak Properties in the second quarter valued at $234,600,000. Norges Bank purchased a new stake in Healthpeak Properties during the 4th quarter worth about $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock worth $153,520,000 after buying an additional 7,007,777 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Healthpeak Properties by 60.3% in the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust's stock valued at $253,949,000 after acquiring an additional 5,815,189 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. raised its position in shares of Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock worth $476,744,000 after acquiring an additional 4,776,056 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

Wall Street Analysts Forecast Growth

DOC has been the subject of several recent analyst reports. Raymond James Financial initiated coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They set a "market perform" rating for the company. Evercore lowered shares of Healthpeak Properties from an "outperform" rating to an "in-line" rating and set a $21.00 price target on the stock. in a research note on Monday, May 11th. Morgan Stanley reissued an "equal weight" rating and set a $22.00 price objective (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Mizuho boosted their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research report on Monday, July 6th. Finally, Citigroup upped their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a "neutral" rating in a report on Tuesday, August 11th. Four research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $21.72.

Healthpeak Properties Trading Down 0.8%

Shares of Healthpeak Properties stock opened at $20.80 on Tuesday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. The company has a market capitalization of $14.34 billion, a P/E ratio of 59.43, a PEG ratio of 2.29 and a beta of 1.01. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $22.95. The company's fifty day moving average is $21.56 and its two-hundred day moving average is $19.23.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business had revenue of $771.58 million during the quarter, compared to analysts' expectations of $725.64 million. During the same period in the prior year, the company earned $0.46 earnings per share. The business's revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Analysts forecast that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be paid a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.9%. Healthpeak Properties's dividend payout ratio is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source